Derendorf H, Möllmann H, Barth J, Möllmann C, Tunn S, Krieg M
Department of Pharmaceutics, University of Florida, Gainesville 32610.
J Clin Pharmacol. 1991 May;31(5):473-6. doi: 10.1002/j.1552-4604.1991.tb01906.x.
The pharmacokinetics of 20 mg hydrocortisone were studied after IV and oral administration. Endogenous hydrocortisone was suppressed by dexamethasone administration. Hydrocortisone concentrations were measured in plasma and saliva. After IV administration, hydrocortisone was eliminated with a total body clearance of 18 L/hr and a half-life of 1.7 hr. The volume of distribution was 34 L. Oral bioavailability averaged 96%. Absorption was rapid, achieving maximum hydrocortisone levels of 300 ng/mL after 1 hour. Saliva levels were not proportional to plasma levels, but could be shown to reflect free, non-protein bound hydrocortisone concentrations in plasma.
研究了静脉注射和口服20毫克氢化可的松后的药代动力学。地塞米松给药可抑制内源性氢化可的松。测量了血浆和唾液中的氢化可的松浓度。静脉注射后,氢化可的松的全身清除率为18升/小时,半衰期为1.7小时,被清除。分布容积为34升。口服生物利用度平均为96%。吸收迅速,1小时后氢化可的松水平达到最高300纳克/毫升。唾液水平与血浆水平不成比例,但可显示反映血浆中游离的、未与蛋白质结合的氢化可的松浓度。